A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of ...

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of ...

DeepSeek-R1 charts a new path for AI through explaining its own reasoning process. Why does this matter and how will it benefit the world?

The future of oncology lies in people-centered care, prioritizing patient needs and leveraging technology to improve cancer treatment and support systems.

AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, today we look at ...

AI’s role in oncology is expanding rapidly, offering new ways to detect, treat, and manage cancer. By analyzing large datasets, AI can uncover patterns and insights that are difficult for humans to ...

C the Signs is using AI to sharpen predictions on cancer risk.

ORNL's AI reduces cancer report processing time from 22 to 14 months, aiding faster cancer trend identification.

A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and Columbia ...

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, ...